ABERDEEN STD GOLD ETF TR's ticker is SGOL and the CUSIP is 00326A104. A total of 222 filers reported holding ABERDEEN STD GOLD ETF TR in Q4 2020. The put-call ratio across all filers is 0.18 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,130 | -61.5% | 63,867 | -60.0% | 0.00% | -60.0% |
Q2 2023 | $2,932 | +14.8% | 159,613 | +18.0% | 0.01% | 0.0% |
Q1 2023 | $2,553 | +4.6% | 135,316 | -3.1% | 0.01% | 0.0% |
Q4 2022 | $2,440 | -99.9% | 139,641 | -0.9% | 0.01% | 0.0% |
Q3 2022 | $2,244,000 | -8.6% | 140,938 | +0.1% | 0.01% | -9.1% |
Q2 2022 | $2,456,000 | -52.3% | 140,814 | -49.2% | 0.01% | -50.0% |
Q1 2022 | $5,151,000 | -0.2% | 277,259 | -5.7% | 0.02% | +10.0% |
Q4 2021 | $5,162,000 | +17.6% | 293,945 | +12.9% | 0.02% | +5.3% |
Q3 2021 | $4,388,000 | -10.0% | 260,431 | -9.2% | 0.02% | -9.5% |
Q2 2021 | $4,874,000 | +8.8% | 286,899 | +5.0% | 0.02% | -4.5% |
Q1 2021 | $4,481,000 | +2.7% | 273,240 | +14.5% | 0.02% | +4.8% |
Q4 2020 | $4,362,000 | +10.2% | 238,612 | +9.4% | 0.02% | -8.7% |
Q3 2020 | $3,958,000 | +4.6% | 218,063 | -1.2% | 0.02% | -4.2% |
Q2 2020 | $3,785,000 | +2180.1% | 220,803 | +1914.6% | 0.02% | +2300.0% |
Q1 2020 | $166,000 | -5.7% | 10,960 | -9.1% | 0.00% | 0.0% |
Q4 2019 | $176,000 | – | 12,060 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Mountain Lake Investment Management LLC | 715,000 | $12,491,050 | 9.49% |
STAPP WEALTH MANAGEMENT, PLLC | 151,197 | $2,642 | 6.33% |
Ameliora Wealth Management Ltd. | 483,191 | $8,441,347 | 4.52% |
Empirical Asset Management, LLC | 228,797 | $3,997,084 | 4.21% |
MILESTONE ASSET MANAGEMENT, LLC | 322,836 | $5,969,238 | 3.55% |
Cypress Capital, LLC | 599,156 | $10,467,255 | 3.46% |
BOS Asset Management, LLC | 208,270 | $3,638,477 | 3.25% |
WT Wealth Management | 366,761 | $6,407,316 | 3.11% |
Newman Dignan & Sheerar, Inc. | 537,044 | $9,382,159 | 3.11% |
Ethos Financial Group, LLC | 510,399 | $8,914,592 | 3.02% |